| abstract |
The aim is to further enhance the antitumor effect when oxaliplatin is used in combination with a mixed formulation comprising tegapur, gimeracyl and oterasyl potassium. By using oxaliplatin in the form of liposome preparations, when the liposome preparations are combined with a mixed preparation comprising tegafur, gimeracil and octeracyl potassium, the antitumor effect can be significantly enhanced without increasing side effects. |